During the past decade, Newland Medical Associates-Pontiac conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 31 clinical trials were completed, i.e. on average, 25.8% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 31 clinical trials were completed. i.e. 57.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Newland Medical Associates-Pontiac" #1 sponsor was "National Cancer Institute (NCI)" with 62 trials, followed by "Alliance for Clinical Trials in Oncology" with 28 trials sponsored, "SWOG Cancer Research Network" with 22 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Newland Medical Associates-Pontiac" #1 collaborator was "National Cancer Institute (NCI)" with 73 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Newland Medical Associates-Pontiac" are "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Newland Medical Associates-Pontiac" in a lesser frequency.

Most popular intervention types in "Newland Medical Associates-Pontiac" are "Drug" (108 trials), "Other" (79 trials), "Biological" (52 trials), "Procedure" (38 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (40 trials), "Laboratory Biomarker Analysis" (29 trials), "Questionnaire Administration" (27 trials), "Biospecimen Collection" (24 trials) and "Computed Tomography" (24 trials). Other intervention names were less common.

The vast majority of trials in "Newland Medical Associates-Pontiac" are 117 trials for "All" genders, 17 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Newland Medical Associates-Pontiac". undefined are not yet recruiting, 52 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Newland Medical Associates-Pontiac, 5 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Newland Medical Associates-Pontiac, 2 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".